RxDoctor Payments DataLook up a doctor →

Natraj Ammakkanavar, MD

Medical Oncology · Indianapolis, INNPI 1376850461

Payments from drug & device makers

$4,140,695in general payments, 2019–2025

Across 793 payments — averaging $5221.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$1.7M
  • AbbVie$1.1M
  • Pfizer$433K
  • Merck$383K
  • Seagen Inc.$328K
  • E.r. Squibb & Sons, L.L.C.$105K
  • plus $128K from 34 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,140,695 in reported general payments places this provider in the 95th percentile of 67 medical oncology providers in Indiana.

See all medical oncology providers in Indiana

Medicare billing

Part B allowed, 2024
$199,607
Medicare patients
659
Services billed
2,362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other medical oncology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →